Test quickly measures efficacy of Alzheimer's drugs

04/13/2009 | Belleville News-Democrat (Ill.)

Researchers said a new called stable isotope-lined kinetics can assess the efficacy of a drug for Alzheimer's disease in only 36 hours. The test was used to show that an Eli Lilly and Co. drug, which is in late-stage trials, reduced the production of amyloid beta. The test might also be used toward hastening the development of Alzheimer's drugs, the researchers said.

View Full Article in:

Belleville News-Democrat (Ill.)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Attorney
Blue Cross Blue Shield of Louisiana
Baton Rouge, LA
Senior or Principal Consultant
PAREXEL International
Nationwide, SL_Nationwide
Chief Financial Officer
Health Alliance Plan of Michigan
Southfield, MI
Senior Vice-President Managed Care Mid-Atlantic Region
Mercy Health System
Conshohocken, PA
Associate Chief Financial Officer
Commonwealth Care Alliance
Boston, MA